An FTA card-based CRISPR/Cas12a platform with isothermal amplification for portable tuberculosis diagnosis
Mycobacterium tuberculosis remains a major global public health threat, imposing significant socioeconomic burdens. Current molecular diagnostics rely heavily on nucleic acid extraction and specialized equipment, which limits their use in resource-limited settings. We developed a rapid, sensitive platform suitable f...